The largest community for pharma industry writers and readers

JOIN 2020 TPMG ONLINE PHARMA SUMMIT

CALL FOR AUTHOR - 2020 FEATURED WRITERS

Meet our featured writers & subscribe to their newsletters

Natalie Yeadon

Jorge Herrera

Tommaso Salanitri

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is “fake news.” We hear it being thrown around by politicians and celebrities alike, not to mention by social media users...

Natalie Yeadon

Impetus Digital Co-Owner/Managing Director

Natalie worked in the pharmaceutical industry for over 18 years in a variety of sales, marketing, and early brand commercialization management roles. Currently, she is the Co-owner and Managing Director of Impetus Digital where she dedicates her time to helping life science companies create sustained and authentic relationships with their key customers through Impetus’ cutting-edge online collaboration platform, the Impetus InSite Platform®.

MORE FROM NATALIE

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the...

Targeting the Tumor Microenvironment

Investigators are always looking for new and innovative ways to treat cancer. This is a constantly and rapidly evolving...

Why Pharma Needs to Care About Global Warming

A version of this article was previously published on Pharmaphorum. Barely a day goes by without global warming or climate...

Medical Marijuana and Cannabinoids for Cancer Therapy

Medical marijuana – or cannabis – is one of the hottest topics in oncology right now. This is especially...

Biologics and Biosimilars in Oncology

With many patents about to expire in coming years, the field of biologics in oncology is about to change...

Real-world Evidence (RWE) for Regulatory and Reimbursement Decisions

We have previously discussed the potential roles of real-world data (RWD) and real-world evidence (RWE) for drug access. However,...

Sign up for NATALIE´s NEWSLETTER

WEBINARS & WHITEPAPERS

CMOs of Pfizer and Sanofi give insight on their digital transformation

Comments and case studies from CMOs and Heads of Medical Affairs on how medical can use digital tools for...

Deliver patient-centered outcomes to be a trusted partner with AstraZeneca, Takeda and Novartis

Thanks to our ability to build a true partnership with our patients, we managed to gain trust and improve...

Time to Embrace Social Media Marketing | December 12 | NY 10:30 Am

  Unsurprisingly, patients and physicians are increasingly turning to social media to find information, make connections and communicate. But instead of...

Digitally transform medical affairs without compromising authenticity

Dear Colleagues: Within pharma companies, medical departments have steadily risen to prominence. As well as having a grip on key...

ON DEMAND WEBINAR: The evolving role of MSLs – insight from Amgen, Novartis and Pfizer

Dear Colleague 52% medical affairs experts believe that medical integrity is maintained in their organization – but is increasingly being...

Make digital your success story: AbbVie, Sanofi, Ferring & Agnitio discuss going digital-first to address HCP priorities

eyeforpharma Webinar (a Reuters Event Company) If you’re an HCP, your first priority is to you and your community. How...

Jorge Herrera

Jorge Herrera

Patient Experience is not Customer Experience and Pharma needs to get this.

The search volume of the term "Patient Experience" increased almost 550% in the past decade. Consultants, agencies, start ups and health care companies have been selling, exploring and adopting the concept, but what could be the ultimate goal? Improving an...

Jorge Herrera

Writer

JORGE HERRERA´S ARCHIVES

The digital game changers in pharma are not digital tools, but new aspirations

Patient centricity, agility and digital capabilities are now the focus of many pharmaceutical companies to evolve one of the...

Suscribe to Jorge Herrera´s Newsletter

COVID-19

BioLab Sciences to Distribute Rapid Antibody Test for COVID-19

PHOENIX--(BUSINESS WIRE)--BioLab Sciences, a regenerative biotechnology company, today announced they are now distributing tests to detect antibodies specific to...

Komodo Health Teams Up with Karyopharm Therapeutics to Accelerate New Global Clinical Trial to Treat Patients with COVID-19

SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health today announced a collaboration with Karyopharm Therapeutics Inc. (Nasdaq: KPTI) to accelerate clinical trial recruitment...

Avacta and Cytiva Collaborating on COVID-19 Rapid Test

CAMBRIDGE, England & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased...

Sermo Reports Hydroxychloroquine Usage Expands Globally, Plasma Is Perceived as More Effective Than Hydroxychloroquine, Remdesivir Efficacy Perceptions on the Rise

NEW YORK--(BUSINESS WIRE)--Week two data of the Barometer study from 5,000 physicians in 30 countries conducted by Sermo reveals...

PharmaCyte Biotech Enters into License Agreement for COVID-19 Diagnostic Kits

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and...

Biodesix Begins Coronavirus COVID-19 Testing

BOULDER, Co.--(BUSINESS WIRE)--Biodesix, Inc., a leading diagnostic company in lung disease, today announced that it began SARS-CoV-2 Droplet Digital...

Tommaso Salanitri

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a new market/therapeutic area. A “Go-to-Market” strategy generally has, as main objectives, to: Ensure a successful product launch defining plan and direction...

Tommaso Salanitri

Writer

TOMMASO SALANITRI´S ARCHIVES

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Field Medical Affairs In Pharma/Biotech: Effectiveness, Opportunities and Challenges

  Medical Affairs has risen very fast in the last years, becoming after an initial phase of “supporting function”, a...

Medical Insights in Pharma Industry by Tommaso Salanitri

Gain an insight means obtain an accurate and deep understanding about some (complex) situation. Medical insights represent one of the most...

Business Analysis in Pharma Industry: from Market Research to Patient Journey. A Medical Affairs view

by Tommaso Salanitri, MD Business analysis in Pharma industry, either during the early phases of drug development phase or close...

Business Plan: a Medical Affairs perspective

A business plan is generally considered a process and specifically, a document, that summarizes the operational and financial objectives...

Suscribe to Tomasso Salanitri´s Newsletter